PAXCEED Trademark

Trademark Overview

On Monday, February 25, 2002, a trademark application was filed for PAXCEED with the United States Patent and Trademark Office. The USPTO has given the PAXCEED trademark a serial number of 78110915. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 28, 2012. This trademark is owned by Angiotech Pharmaceuticals, Inc.. The PAXCEED trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, pharmaceuticals for the treatment of multiple sclerosis; pharmaceuticals for the treatment of arthritis; and pharmaceuticals for the treatment of psoriasis; all being administered only by injection or infusion
paxceed

General Information

Serial Number78110915
Word MarkPAXCEED
Filing DateMonday, February 25, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 28, 2012
Registration Number3048457
Registration DateTuesday, January 24, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2005

Trademark Statements

Goods and ServicesPharmaceuticals, namely, pharmaceuticals for the treatment of multiple sclerosis; pharmaceuticals for the treatment of arthritis; and pharmaceuticals for the treatment of psoriasis; all being administered only by injection or infusion

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 28, 2012
Primary Code005
First Use Anywhere DateFriday, August 31, 2001
First Use In Commerce DateThursday, August 15, 2002

Trademark Owner History

Party NameAngiotech Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressVancouver, British Columbia V6T 1Z4
CA
Party NameAngiotech Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVancouver, British Columbia V6T 1Z4
CA
Party NameAngiotech Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, British Columbia V6T 1Z4
CA

Trademark Events

Event DateEvent Description
Friday, September 28, 2012CANCELLED SEC. 8 (6-YR)
Tuesday, October 24, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 24, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, November 1, 2005PUBLISHED FOR OPPOSITION
Wednesday, October 12, 2005NOTICE OF PUBLICATION
Thursday, September 1, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 26, 2005ASSIGNED TO LIE
Monday, August 22, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 22, 2005EXAMINERS AMENDMENT E-MAILED
Monday, August 22, 2005EXAMINERS AMENDMENT -WRITTEN
Monday, August 22, 2005PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, August 22, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 22, 2005USE AMENDMENT ACCEPTED
Tuesday, August 2, 2005AMENDMENT FROM APPLICANT ENTERED
Monday, July 25, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 2, 2005AMENDMENT TO USE PROCESSING COMPLETE
Monday, July 25, 2005USE AMENDMENT FILED
Monday, July 25, 2005PAPER RECEIVED
Tuesday, May 10, 2005INQUIRY TO SUSPENSION E-MAILED
Tuesday, May 10, 2005SUSPENSION INQUIRY WRITTEN
Thursday, April 28, 2005LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, October 22, 2004LETTER OF SUSPENSION E-MAILED
Friday, October 22, 2004SUSPENSION LETTER WRITTEN
Wednesday, October 13, 2004TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 28, 2004UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Tuesday, September 28, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 14, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 8, 2004INQUIRY TO SUSPENSION E-MAILED
Monday, March 22, 2004CASE FILE IN TICRS
Monday, March 22, 2004CASE FILE IN TICRS
Wednesday, May 14, 2003ASSIGNED TO EXAMINER
Thursday, September 12, 2002LETTER OF SUSPENSION E-MAILED
Friday, July 26, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 26, 2002TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 26, 2002TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 17, 2002NON-FINAL ACTION E-MAILED
Tuesday, June 11, 2002ASSIGNED TO EXAMINER

Related Keywords

paxceed pharmaceuticals treatment administered only injection infusion being arthritis namely multiple